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Facts
The fact that reduced heart rate variability or, perhaps more
accurately, reduced "heart period variability" is a powerful
predictor of arrhythmia-related complications in patients
surviving the acute phase of myocardial infarction is not
disputable. After the initial report by Wolf et al . (1), who
related diminished sinus arrhythmia to mortality during the
early in-hospital subacute phase of infarction, the high
predictive power of reduced heart rate variability has been
shown in many risk stratification studies (2,3) that dealt
predominantly with the early and late chronic phases of
infarction . The size of the total population of all these studies
can compete with populations of very large international
clinical trials and makes the conclusion that reduced heart
rate variability is indeed a strong risk predictor difficult to
neglect .
Many experimental investigations have addressed the
physiologic and pathophysiologic mechanisms that make
reduced heart rate variability such a strong risk predictor . In
one of the seminal studies, Akse!rod et al . (4) distinguished
three constituents of heart rate variations, namely, high,
medium and low frequency components that they associated
with autonomic nervous system and other regulatory mech-
anisms. Their conclusions have been reproduced by others
and it is now generally accepted that the high frequency
components of heart rate variability are almost exclusively
driven by the parasympathetic system and the medium
frequency components predominantly by the sympathetic
system with a contribution from the paaasympathetic sys-
tem. The physiologic background of the very low frequency
components is much less understood . Other seminal studies
(5) have shown that reduced parasympathetic tone or the
predominance of sympathetic over vagal stimulation is ar-
rythmogenic. The perception is that preserved vagal tone
provides an "antiarrhythmic defense," probably by altering
excitability of cardiac cells .
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The deductions provided by these experimental investi-
gations are in good agreement with results of investigations
• heart rate variability irs animal models of myocardial
infarction. It has been shown in a dog model (6), that the
acute infarction reduces the level of heart rate variability and
that the reduction is greater in animals that are susceptible to
arrhythmic complications . Thus, if the pathologic processes
• acute infarction would be expected to change the auto-
nomic input to the heart, they would, in some cases, also
destroy or at least impair the natural antiarrhythmic defense
provided by vagal tone .
Controversies
On the basis of all these facts, a simple hypothesis was
proposed that the reduced heart rate variability is simply a
reflection of diminished parasympathetic input to the heart
and that it consequently marks the loss of vagal protection
against proarrhythmic effects of premature depolarization,
excitation reflection and other arrhythmia-triggering mecha-
nisms. Unfortunately, this hypothesis, although elegant, is
not supported by all the clinical observations .
A strong suggestion that the predictive power of reduced
heart rate variability is not a mere echo of depressed vagal
antiarrhythmic defense came from a study of Bigger et al .
(7), who observed that the predictive power of ultralow
frequency components of heart rate variability (that is, those
on the opposite end of the spectrum) is substantially higher
than the predictive power of reduced vagal components .
Moreover, the sympathetic (or predominantly sympathetic)
components of heart rate variability are also depressed in
survivors of myocardial infarction who later experience
arrhythmia-related complications. This observation does not
correspond to results in animal models, which showed
sympathetic dominance to be an arrythmogenic feature .
An earlier study from our own group (8) suggested that to
achieve the maximal predictive power of reduced heart rate
variability after myocardial infarction, the measurement of
heart rate variability should involve the period between early
morning and early afternoon. Because such a period does
not correspond to that when maximal vagal activity might be
expected in hospitalized patients, the observation is also at
variance with the data from animal experiments. In addition,
we observed that, heart rate variability assessed in se-
quential short-term intervals (20 min) varies considerably
in low risk patients and that even these patients have
frequent episodes of depressed vagal tone . Thus, the vagal
antiarrhythmic protection is not constantly present in low
risk patients .
If reduced heart rate variability reflects diminished vagal
antiarrhythmic protection, one might also have difficulty
explaining why the baroreflex sensitivity assessed in survi-
vors of myocardial infarction does not more strongly corre-
late with heart rate variability (9). There is a conceptual
difference between baroreflex sensitivity and heart rate
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variability : Baroreflex sensitivity assesses parasympathetic
input to the heart in response to a maximal stimulation
whereas heart rate variability is a reflection of a physiologic
"tone." Nevertheless, it is the discrepancy rather than the
similarity between these two measures that is str-king .
In this issue of JACC, Vybiral et al . (10) repc : -t a study
that contributes to the discrepancies between the results of
pathophysiologic experiments and clinical observations . The
study compared heart rate variability in patients who devel-
oped ventricular fibrillation during monitoring and in com-
parable patients who had coronary artery disease but no
history of sudden cardiac death. If the "vagal depression"
hypothesis of heart rate variability is correct, the patients
who developed fibrillation during the recording might exhibit
the lowest heart rate variability just before fibrillation,
especially as they had frequent ventricular ectopic beats and
short runs of nonsustained ventricular tachycardia and
therefore did not lack fibrillation triggers . If the tachycardia
and fibrillation triggers are almost constantly present, one
would assume that the arrhythmia would be initiated when
the autonomic defense would be least present . Yet Vybiral et
al. did not observe any systematic differences between
baseline heart rate variability and that of sinus rhythm before
fibrillation onset . Although this result contradicts observa-
tions previously made by Singer et al . (11), the study makes
a strong point in this respect .
It is probably less important that Vybiral et al . did not
find any differences in heart rate variability between the
ventricular fibrillation and the control patient groups . Be-
cause they tried to select the closest possible match of the
control group (especially with respect to the incidence of
nonsustained tachycardia), they also masked the differences
between the patients with ventricular fibrillation and true
low risk. groups .
Fancies
It is difficult, if not directly impossible at present, to
suggest an explanation for these discrepancies between
laboratory-based hypotheses and clinical reality. Neverthe-
less, some frequently neglected factors that might seriously
influence clinical interpretation of heart rate variability
should be mentioned .
The so-called time domain data-processing methods that
are frequently used to measure heart rate variability are
rather primitive and give only rough estimates of heart rate
variations . Vybiral correctly points out that the conventional
indexes of heart rate variability are not focused enough to
differentiate delicate perturbations of the autonomic nervous
system. Indeed, the frequently used standard deviation of
RR intervals does not even standardize the heart rate vari-
ability value for the dynamic changes of heart rate. One
might try to detect subtle changes by frequency analysis of
heart rate variability but, unfortunately, the confidence that
many researchers have in these techniques is not generally
justified. The persisting problems caused by changes in the
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environmentt during recording and the dif ficulties arising
when analyzing Holler records with many ectopic beats (as
was the case in the study of Vybiral et al
.) make the current
frequency domain methods equally primitive and coarse for
the analysis of clinical data .
An experimental animal can be more easily brought than
can a human subject into a stationary stage that makes the
results of heart rate variability frequency analysis more
physiologicahy interpretable . Unless human subjects are
recorded under very strict conditions (with metronome
controlled respiration, for example), it is difficult to directly
compare results in the experimental animal with those in
humans. Naturally, such strict conditions are not easily
achievable in clinical studies (and completely unachievable
in such studies as that of Vybiral et al .) and the difference
between the quality of analyzed data might partly if not
substantially account iii the discrepancies between the
results of animal experiments and clinical observations .
A lack of stationariness in the data analyzed by frequency
domain methods might be much more important than is
usually perceived . If, say, the parasympathetic input to the
heart were to exhibit a very strong circadian pattern slowing
the heart rate in very long cycles, these variations would be
detected as ultralow frequency components and the rele-
vance of the vagal system would be lost .
Another aspect that makes the dog and other animal
models not easily app'ica, .hle to humans is human psychol-
ogy. Reduced heart rate variability in patients at high risk
might ba a marker of both depressed autonomic tone and
diminished psychologic responses to the environment . If this
is the case, the conclusions of Vybiral et al . and of the other
clinical studies are less surprising .
Whether the depressed heart rate variability in post-
infarction patients is a complex multifactorial marker of
arrhythmia risk or whether it has a more direct mechanistic
relation to the proarrhythmic substrate, triggers and mech-
anisms is not known . Psychologic tensions, stress and men-
tal concentration are known to influence heart rate variabil-
ity and if the psychosomatic processes play an important
role in preserving or depressing heart rate variability after an
acute infartion, a direct mechanistic relation of depressed
heart rate variability to arrhythmia is not very probable .
Thus, the strong association of depressed heart rate variabil-
ity with arrhythmia-related complications might be just a
lucky combination of several factors that make the de-
pressed heart rate variability such an important but meLha-
nistically irrelevant marker .
Our lack of a full understanding of the background of
depressed heart rate variability does not make its clinical
importance less valid . Nevertheless, more clinical studies
such as that of Vybiral et al . are needed to improve our
perception of heart rate variability . Increased unt=crstanding
of the physiologic background will naturally make the clini-
cal utilization of this observation more focused and more
powerful .
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